Measurement of novel tear fluid biomarkers in increasingly prevalent retinal eye diseases: Improving diagnostic in AMD, DR/DME and glaucoma
Laufzeit: 01.01.2018 - 31.12.2023
imported
Kurzfassung
Measurement of novel tear fluid biomarkers in increasingly prevalent retinal eye diseases: Improving diagnostic in AMD, DR/DME and glaucoma
